NRF2-targeted therapeutics: New targets and modes of NRF2 regulation

Current Opinion in Toxicology
Montserrat Rojo de la VegaDonna D Zhang

Abstract

Pharmacological activation of the transcription factor nuclear factor-erythroid derived 2-like 2 (NRF2), the key regulator of the cellular antioxidant response, has been recognized as a feasible strategy to reduce oxidative/electrophilic stress and prevent carcinogenesis or other chronic illnesses, such as diabetes and chronic kidney disease. In contrast, due to the discovery of the "dark side" of NRF2, where prolonged activation of NRF2 causes tissue damage, cancer progression, or chemoresistance, efforts have been devoted to identify inhibitors. Currently, only one NRF2 activator has been approved for use in the clinic, while no specific NRF2 inhibitors have been discovered. Future development of NRF2-targeted therapeutics should be based on our current understanding of the regulatory mechanisms of this protein. In addition to the KEAP1-dependent mechanisms, the recent discovery of other pathways involved in the degradation of NRF2 have opened up new possibilities for the development of safe and specific therapeutics. Here, we review available and putative NRF2-targeted therapeutics and discuss their modes of action as well as their potential for disease prevention and treatment.

References

Jan 1, 1978·Advances in Cancer Research·L W Wattenberg
Dec 2, 2004·Molecular and Cellular Biology·Donna D ZhangMark Hannink
Dec 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiu Jun WangC Roland Wolf
Oct 8, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alexandria LauDonna D Zhang
Jun 29, 2010·Nature Biotechnology·Stephen OrlickyMike Tyers
Jul 27, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Georg Thomas WondrakDonna D Zhang
Aug 28, 2010·Cancer Metastasis Reviews·Limin ShuAh-Ng Kong
Jan 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Dongmei RenDonna D Zhang
Oct 18, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Giel HendriksHarry Vrieling
Nov 24, 2011·Free Radical Biology & Medicine·Rowena HancockGeoff Wells
Sep 4, 2012·Antioxidants & Redox Signaling·Alison C BrewerIvor J Benjamin
Sep 21, 2012·The New England Journal of Medicine·Ralf GoldUNKNOWN DEFINE Study Investigators
Dec 12, 2012·Antioxidants & Redox Signaling·Donna D Zhang
Apr 9, 2013·Bioorganic & Medicinal Chemistry Letters·Longqin HuBenito Munoz
May 8, 2013·Bioorganic & Medicinal Chemistry·Douglas MarcotteLaura Silvian
Jul 11, 2013·Journal of Medicinal Chemistry·Anthony J WilsonChristopher J Moody
Sep 10, 2013·Molecular Cell·Yoshinobu IchimuraMasaaki Komatsu
Oct 22, 2013·Genes & Development·Melba C Jaramillo, Donna D Zhang
Nov 23, 2013·Free Radical Biology & Medicine·Takumi SatohStuart A Lipton
Mar 19, 2014·Genes & Development·Tongde WuDonna D Zhang
Aug 12, 2014·Biochimica Et Biophysica Acta·Frank ChristianGeorge S Baillie
Sep 27, 2014·Cell Death and Differentiation·Y Liu, B Levine
Dec 3, 2014·Drug Discovery Today·Keld Fosgerau, Torsten Hoffmann
Dec 30, 2014·Reviews in Endocrine & Metabolic Disorders·Zhiguo ZhangLu Cai
Nov 10, 2015·Biochemical Society Transactions·Geoff Wells
Dec 30, 2015·Molecular & Cellular Proteomics : MCP·Steffan VartanianDavid Stokoe
Mar 13, 2016·Seminars in Oncology·Li YangThomas W Kensler

❮ Previous
Next ❯

Citations

Sep 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hongbin DaiZhengyu Jiang
Sep 27, 2018·Annual Review of Pharmacology and Toxicology·Matthew DodsonDonna D Zhang
Jan 25, 2019·Current Pharmaceutical Design·Gina MandaAntonio Cuadrado
Jul 20, 2019·Phytotherapy Research : PTR·Alireza TavakkoliGholamreza Karimi
Sep 27, 2019·Current Developments in Nutrition·Rattiyaporn Kanlaya, Visith Thongboonkerd
Aug 17, 2019·PloS One·Doumet Georges HelouSylvie Chollet-Martin
May 14, 2020·Natural Product Reports·Donna D Zhang, Eli Chapman
Oct 31, 2017·Current Pathobiology Reports·Matthew Dodson, Donna D Zhang
Jun 27, 2019·Food & Function·Shoujiao PengJianguo Fang
May 13, 2018·Annals of the New York Academy of Sciences·Shaohua MaXiaoxin Luke Chen
Jun 28, 2018·Cellular and Molecular Life Sciences : CMLS·Ning ZhaoTao Zeng
Jul 3, 2021·Cells·Nicola MoscaGiorgio Tasca
Aug 7, 2021·Cellular Signalling·Chorlada PaiboonrungruangXiaoxin Chen
Aug 15, 2021·Trends in Pharmacological Sciences·Adriana A GarciaDaria Mochly-Rosen
Jul 13, 2019·Journal of Agricultural and Food Chemistry·Yanan HouJianguo Fang
Jul 11, 2018·ACS Chemical Neuroscience·Yanan HouJianguo Fang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.